Tag

Contract Research, Development and Manufacturing Organization (CRDMO)

1 article

Anthem Q1 Revenue Down 23% YoY

Anthem Biosciences reported Q1FY27 unaudited consolidated revenue of ₹4,182 Mn, a 22.6% YoY decline. EBITDA stood at ₹1,755 Mn with margins of 39.6%, while PAT was ₹1,199 Mn, up 11.7% YoY. Management